Date | Price Target | Rating | Analyst |
---|---|---|---|
9/12/2024 | $42.00 | Equal Weight | Wells Fargo |
8/27/2024 | $55.00 | Buy | Redburn Atlantic |
8/6/2024 | $46.00 → $44.00 | Overweight → Neutral | JP Morgan |
1/19/2024 | $40.00 → $41.00 | Buy → Neutral | Citigroup |
1/4/2024 | $42.00 | Market Perform | TD Cowen |
11/29/2023 | $32.00 | Outperform → In-line | Evercore ISI |
10/5/2023 | Peer Perform | Wolfe Research | |
5/19/2023 | $40.00 | Buy | Citigroup |
N-PX - Carlyle Group Inc. (0001527166) (Filer)
13F-HR - Carlyle Group Inc. (0001527166) (Filer)
S-8 - Carlyle Group Inc. (0001527166) (Filer)
Wells Fargo initiated coverage of Carlyle Group with a rating of Equal Weight and set a new price target of $42.00
Redburn Atlantic initiated coverage of Carlyle Group with a rating of Buy and set a new price target of $55.00
JP Morgan downgraded Carlyle Group from Overweight to Neutral and set a new price target of $44.00 from $46.00 previously
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
4 - Carlyle Group Inc. (0001527166) (Issuer)
New Home Loan Category Supported by New Carlyle Investment Offers Interest-Only, Below-Market Monthly Payments to Fund Personal Goals Without Selling Assets or Increasing Debts SAN FRANCISCO, Sept. 17, 2024 /PRNewswire/ -- Unison, the pioneer of equity sharing agreements, today announced the launch of the Unison Equity Sharing Home Loan, which enables homeowners to receive cash today at below-market rates. Unison launches new Equity Sharing Home Loan that enables homeowners to receive cash today at below-market rates.Today, the company also announced that global investment firm Carlyle (NASDAQ:CG) has entered into an agreement to purchase up to $300 million of equity sharing home loans fr
NEW YORK, Sept. 16, 2024 /PRNewswire/ -- Global investment firm Carlyle (NASDAQ:CG) today announced a strategic investment into North Bridge ESG LLC ("North Bridge"), a leading provider of real estate finance solutions, and a commitment to provide up to $1 billion to facilitate the origination of commercial property assessed clean energy (C-PACE) loans by North Bridge. This partnership leverages Carlyle's strategic growth, real estate, and asset-backed finance expertise and enables North Bridge to address evolving market needs on a larger scale. North Bridge provides C-PACE fi
Altas Partners joins Carlyle and Stone Point Capital as strategic investors Investment will foster continued growth of global claims management provider MEMPHIS, Tenn., Sept. 12, 2024 /PRNewswire/ -- Sedgwick, a leading global provider of claims management, loss adjusting and technology-enabled business solutions, announced a strategic investment from Altas Partners ("Altas"), a North American private equity firm. Current investors, including funds managed by global investment firm Carlyle (NASDAQ:CG) and by Stone Point Capital LLC, will remain as investors and continue to make significant new investments in the business, with Carlyle maintaining its control position in partnership with the
London, UK and New York, USA, September 10, 2024 - Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced the appointment of Robert (Bob) DeBenedetto as Managing Director – Clinical Co-Development. Bob brings to Abingworth over 30 years of experience in the life sciences industry and will be working on Clinical Co-Development deals and execution with new and existing Abingworth portfolio companies. He will be based in Abingworth's Menlo Park, CA, USA office. Prior to joining Abingworth, Bob was the Founder, President and CEO of SFJ Pharmaceuticals Inc. (CA, USA), an Abingworth portfolio company, where he
MCLEAN, Va., July 23, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, has named Brett Barton as Senior Vice President (SVP) of Client Experience. In this newly created role, Barton will represent the voice of the client across multiple touchpoints to deliver an exceptional experience that supports continued growth for the company and elevates the Acentra Health brand. Barton brings over three decades of experience in healthcare technology and services supporting the public sector and health and human services market. He comes to Acentra Health from Gainwell
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova PartnersFunds will be used to build out Myricx Bio's proprietary N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform and advance its pipeline of NMTi-ADCs through clinical proof of concept targeting clinically validated tumour-associated antigensCompany to establish laboratory operations in London's biotech hub, and expand its management and R&D teamsMichael Bauer from Novo Holdings and Lucille Conroy from Abi
Ares Management Corp. (NYSE:ARES) and HPS Investment Partners are spearheading a $3 billion credit facility to finance Carlyle Group Inc.’s (NASDAQ:CG) potential acquisition of Baxter International Inc.’s (NYSE:BAX) kidney-care division. This debt package includes a $2.5 billion unitranche loan and a $450 million revolver. Oaktree Capital Management is also involved in the financing, and smaller lenders may participate after signing. Also Read: Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System. The financing terms suggest an interest rate five percentage points above the Secured Overnight Financing Rate, placing the division Vantive’s leverage at 4.2
https://www.bloomberg.com/news/articles/2024-07-23/ares-hps-line-up-3-billion-debt-for-carlyle-s-baxter-unit-bid?sref=y3YMCJ4e
Directors Robert Langer and Stephen Berenson will also retire from the Board.
SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D - Carlyle Group Inc. (0001527166) (Filed by)
SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)
Sale simplifies Advance's enterprise structure and sharpens focus on the blended box business Net proceeds to be used primarily to strengthen balance sheet and invest in the business Advance Auto Parts, Inc. (NYSE:AAP), a leading automotive aftermarket parts provider in North America that serves both professional installer and do-it-yourself customers, announced that it has entered into a definitive agreement to sell Worldpac, Inc., an automotive parts wholesale distribution business, to funds managed by global investment firm Carlyle (NASDAQ:CG) for $1.5 billion in cash. The transaction is expected to close before the end of the year. "We are pleased to announce the sale of the World
NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its second quarter ended June 30, 2024. Justin Plouffe, CGBD's Chief Executive Officer said, "Our core middle-market strategy and active approach to portfolio management continued to drive strong performance in the second quarter of 2024, as we maintained a dynamic approach to origination in an increasingly competitive market. With increased volume during the quarter, we capitalized on attractive origination opportunities, and we see the potential for increased deal ac
Provides meaningful scale and diversity to CGBD through addition of a Carlyle-managed portfolio Carlyle to exchange CGBD convertible preferred stock for CGBD common stock at NAV, eliminating current 5% – 8% preferred stock dilution overhang Advisors agreed to cover transaction costs in certain circumstances up to a total cap of $5 million NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD), a business development company focused on directly-originated lending to sponsor-backed U.S. middle market companies, has entered into a definitive agreement to acquire Carly